mhc
locat
within
mb
region
human
chromosom
region
encod
gene
approxim
immun
relat
function
extens
linkag
disequilibrium
high
degre
sequenc
variat
contribut
complex
mhc
polymorph
region
found
insid
mhci
mhcii
loci
contain
gene
encod
mhc
class
ii
molecul
mhcii
locu
also
contain
number
mostli
gene
encod
protein
involv
process
edit
transport
ag
present
mhc
molecul
besid
ag
mhcii
molecul
present
cell
import
maintain
size
peripher
pool
toler
establish
elimin
autoreact
cell
thymu
gener
regulatori
cell
treg
cell
well
sever
peripher
mechan
anergi
delet
autoreact
cell
best
character
nevertheless
human
control
mechan
suffici
autoimmun
ensu
genet
risk
associ
autoimmun
larg
govern
gene
mhc
particular
account
approxim
herit
rheumatoid
arthriti
ra
studi
mechan
underli
autoimmun
anim
model
establish
broken
activ
immun
ag
mice
rat
immun
ag
even
ubiquit
express
protein
induc
autoimmun
induc
type
autoimmun
often
depend
cell
recogn
specif
complex
exampl
arthriti
cia
peptid
deriv
type
ii
collagen
present
crucial
develop
diseas
howev
ensu
autoimmun
model
necessarili
induc
autolog
epitop
mice
immun
rat
bovin
chicken
cii
exampl
respond
strongli
stimul
heterolog
cii
rel
weakli
autolog
mous
cii
arthriti
model
depend
administr
exogen
ag
arthriti
pia
rat
pristan
satur
natur
occur
hydrocarbon
use
ascit
product
induct
lupu
mice
da
rat
singl
intraderm
inject
pristan
induc
chronic
relaps
polyarthr
remain
activ
least
day
diseas
onset
earli
highli
synchron
anim
accompani
elev
level
rheumatoid
factor
strong
acut
phase
respons
induct
arthriti
appear
depend
b
cell
product
antibodi
sinc
adopt
transfer
cell
rat
inject
pristan
induc
diseas
rat
close
mimic
manifest
pia
similar
ra
pia
associ
multipl
discret
loci
mhc
two
map
high
resolut
locu
mb
interv
denot
cell
select
qtl
analysi
strain
demonstr
certain
mhcii
allel
promot
pia
wherea
allel
confer
protect
effect
function
studi
analysi
code
variant
differ
strain
suggest
rat
orthologu
human
respons
use
strain
investig
differ
mhcii
allel
influenc
differenti
rat
inject
pristan
show
pristan
administr
induc
bias
immun
respons
rat
mhcii
allel
hallmark
cytokin
necessari
develop
pia
moreov
upon
pristan
administr
cell
strain
promot
mhcii
allel
acquir
arthritogen
capac
earlier
prolif
contain
larger
fraction
cell
compar
strain
protect
mhcii
allel
kb
region
constitut
contain
gene
locat
within
qtl
border
fig
previous
shown
strain
differ
suscept
pia
due
code
polymorph
locu
lesser
extent
show
later
diseas
onset
compar
da
rat
protect
sever
pia
acut
phase
diseas
ie
first
day
pristan
inject
contrast
develop
sever
form
arthriti
earli
onset
present
studi
also
use
two
new
strain
refin
congen
interv
respect
physic
map
strain
see
tuncel
al
develop
pia
compar
arthriti
develop
respect
parent
strain
fig
c
see
also
support
inform
fig
comparison
pia
versu
versu
first
ask
whether
variat
diseas
onset
strain
da
due
extent
prime
cell
requir
becom
arthritogen
test
arthritogen
cell
pristan
administr
perform
adopt
cell
transfer
cell
drain
lymph
node
dln
transfer
one
donor
one
mhcii
syngen
recipi
refer
individu
transfer
see
method
da
rat
donor
cell
requir
minimum
day
prime
vivo
transfer
arthriti
day
becom
fulli
arthritogen
fig
similarli
cell
eight
nine
donor
transfer
arthriti
day
prime
vivo
contrast
interv
suffici
prime
cell
donor
p
versu
da
p
versu
da
donor
transfer
arthriti
fig
identifi
whether
arthritogen
capac
donor
cell
due
qualit
quantit
differ
strain
da
first
assess
frequenc
prolifer
memoryactiv
convent
tconv
cell
rat
frequenc
prolifer
cell
subset
da
increas
day
day
remain
high
least
day
fig
show
fewer
prolifer
memoryactiv
tconv
cell
da
day
day
prolifer
cell
significantli
lower
variat
prolifer
specif
memoryactiv
tconv
cell
also
seen
among
cell
fig
subset
treg
cell
recent
thymic
emigr
rte
support
inform
fig
taken
togeth
earli
onset
da
compar
correl
rapid
expans
arthritogen
effector
cell
rate
prolifer
increas
strain
earli
arthriti
onset
assess
clonal
prolifer
tconv
cell
analyz
cell
dln
rat
use
avail
antibodi
flow
cytometri
frequenc
subset
togeth
constitut
total
repertoir
vari
significantli
strain
fig
tconv
cell
exampl
shown
adopt
transfer
pia
abund
da
rat
frequenc
tconv
cell
highest
howev
except
frequent
da
pristan
administr
rel
frequenc
subset
among
total
tconv
cell
dln
affect
pristan
fig
thu
indic
cell
broad
clonal
origin
like
autoreact
expand
flow
cytometr
analys
treg
cell
rat
reveal
differ
frequenc
number
suscept
protect
strain
support
inform
fig
pristan
inject
rat
show
modest
increas
frequenc
treg
cell
wherea
reduct
treg
cell
compar
da
fig
indic
protect
mhcii
allel
simpli
favor
select
expans
treg
cell
tconv
cell
howev
proport
treg
cell
neg
tumor
necrosi
factor
receptor
almost
higher
compar
strain
fig
may
suggest
significantli
larger
proport
treg
cell
function
suppress
sinc
ligat
treg
cell
shown
turn
suppress
capac
tconv
cell
express
effector
cell
undergon
tcr
ligat
cell
dln
da
show
significantli
higher
proport
cell
day
day
pristan
administr
compar
fig
earli
expans
cell
da
like
explain
cell
strain
arthritogen
day
cell
fig
moreov
variat
treg
cell
frequenc
consid
fig
tregt
effector
cell
ratio
approxim
twofold
higher
compar
da
day
pristan
administr
fig
togeth
data
suggest
promot
mhcii
allel
acceler
onset
pia
expand
cell
clone
pristan
dln
assess
differ
respons
strain
determin
mrna
level
cytokin
transcript
factor
purifi
cell
show
upregul
strain
promot
mhcii
allel
surprisingli
distinct
upregul
signatur
gene
cell
fig
similar
shift
associ
cytokin
observ
stimul
cell
da
rat
vitro
fig
flow
cytometr
analys
cell
show
produc
cell
increas
approxim
twofold
day
day
da
rat
fig
contrast
frequenc
cell
margin
increas
first
day
pia
total
number
cell
significantli
increas
dln
da
compar
day
immun
fig
unlik
unstimul
cell
fig
cell
stimul
fig
pmaionomycin
stimul
reveal
signific
differ
express
strain
data
shown
total
number
cell
fig
taken
togeth
data
show
pristan
administr
cell
differenti
predominantli
lineag
rat
arthriti
suscept
mhcii
allel
signific
expans
cell
observ
strain
pia
probe
whether
critic
induct
arthriti
treat
rat
neutral
antibodi
day
pristan
administr
rat
regardless
mhcii
haplotyp
treat
ab
develop
significantli
milder
diseas
compar
control
rat
fig
wherea
effect
observ
treat
ab
fig
addit
onset
pia
delay
day
rat
treat
ab
fig
suggest
prime
pia
also
strain
associ
bias
immun
respons
next
assess
whether
andor
requir
progress
establish
arthriti
inject
neutral
antibodi
day
pristan
administr
fig
effect
neutral
arthriti
progress
neglig
promot
fig
strain
except
slow
diseas
develop
fig
neutral
contrast
highli
effici
suppress
progress
diseas
strain
fig
effect
neutral
follow
twofold
reduct
circul
neutrophil
fig
suggest
oper
granulopoiesi
recruit
neutrophil
joint
pia
compel
evid
contribut
patholog
number
autoimmun
diseas
defici
mice
exampl
protect
arthriti
deplet
shown
suppress
prime
respons
well
progress
ongo
diseas
addit
enrich
blood
synovi
fluid
patient
ra
suggest
might
import
also
human
ra
comparison
role
autoimmun
arthriti
controversi
probabl
modu
operandi
depend
context
show
activ
autoreact
cell
administr
hydrocarbon
skew
immun
respons
toward
neutral
protect
rat
develop
sever
arthriti
importantli
found
earli
signatur
domin
rat
express
mhcii
allel
provid
link
effector
differenti
diseas
phenotyp
mhcii
genotyp
mhcii
locu
confer
highest
genet
risk
ra
major
impact
permiss
mhcii
allel
like
earli
diseas
develop
although
poorli
character
human
preclin
stage
arthriti
like
involv
seri
link
event
eventu
caus
breech
toler
activ
b
cell
respons
attack
peripher
joint
howev
event
necessari
need
unfold
joint
fact
telomer
length
studi
shown
cell
recruit
joint
state
suggest
joint
primari
organ
cognat
respons
also
suggest
cell
polyclon
origin
howev
cell
remain
larg
unknown
even
modifi
peptid
peptid
weak
affin
mhcii
could
serv
potenti
target
ag
similar
seri
event
albeit
time
frame
may
lead
develop
pia
rat
first
pristan
hydrocarbon
bind
mhcii
molecul
unlik
pristan
oper
directli
cell
present
instead
function
genet
data
suggest
stimul
innat
signal
receptor
prr
receptor
lectin
receptor
import
trigger
adapt
respons
pia
although
never
formal
exclud
pristan
present
block
interact
prime
day
post
pristan
suffici
amelior
pia
second
activ
dendrit
cell
appear
import
prime
autoreact
cell
pia
third
inject
hexadecan
shown
miner
oil
accumul
within
dln
detect
oil
found
joint
suggest
primari
site
activ
within
lymphoid
organ
data
suggest
primari
site
activ
ln
drain
inject
site
cell
locat
could
transfer
arthriti
earli
day
pristan
administr
show
expand
cell
dln
broad
clonal
consist
previou
studi
show
arthritogen
cell
pia
use
divers
repertoir
tcr
chain
molecul
specif
upregul
cell
shown
promot
clonal
expans
surviv
effector
memori
cell
assess
earli
express
pristan
dln
found
posit
effector
cell
enrich
dln
rat
carri
mhcii
allel
express
peak
around
day
pristan
inject
coincid
emerg
arthritogen
cell
da
rat
establish
signatur
strain
togeth
find
provid
possibl
explan
earli
arthriti
onset
associ
certain
mhcii
allel
name
rapid
expans
differenti
cell
arthritogen
effector
cell
contrast
role
tconv
cell
role
treg
cell
remain
controversi
sever
studi
shown
ligat
treg
cell
dampen
regulatori
activ
presenc
favor
expans
effector
cell
treg
cell
could
explain
expans
effector
cell
observ
da
pristan
administr
local
cytokin
milieu
high
would
favor
effector
treg
cell
prolifer
moreov
high
express
treg
cell
da
could
associ
poor
immun
regulatori
function
strain
could
amplifi
ongo
expans
autoreact
cell
even
consist
notion
also
cell
restrict
mhcii
essenti
develop
pia
show
greater
prolifer
strain
arthriti
promot
mhcii
allel
prolifer
could
associ
express
treg
cell
sinc
growth
factor
could
becom
avail
absenc
suffici
treg
suppress
could
mean
treg
cell
consist
larger
proport
neg
cell
better
suppressor
cell
treg
cell
da
howev
defici
treg
cell
also
associ
lack
immun
suppress
shown
coliti
henc
implic
differenti
express
may
treg
cell
pia
relev
may
protect
observ
remain
determin
effector
cell
rat
carri
diseas
promot
mhcii
allel
differenti
cell
upon
pristan
administr
signatur
like
respons
earli
onset
sever
progress
arthriti
da
sinc
neutral
rat
delay
onset
reduc
sever
pia
henc
deplet
prime
da
rat
seem
phenocopi
characterist
diseas
unlik
da
rat
demonstr
propens
develop
immun
instead
cell
express
higher
level
compar
da
suggest
pristan
drive
expans
cell
importantli
expans
produc
cell
seem
pathogen
sinc
deplet
rat
influenc
onset
progress
pia
strain
interestingli
frequenc
total
number
produc
cell
increas
time
reach
level
da
time
arthriti
onset
suggest
expans
autoreact
cell
ultim
determin
onset
pia
type
immun
respons
previous
demonstr
import
induct
arthriti
neutral
inhibit
arthriti
arthriti
pgia
recent
format
neutrophil
extracellular
trap
net
shown
induc
expans
cell
acceler
onset
cia
mice
interestingli
pristan
shown
potent
induc
net
suggest
net
could
serv
induc
immun
pia
mediat
immun
may
also
relev
earli
ra
studi
demonstr
preclin
phase
ra
domin
cytokin
chemokin
moreov
lymph
node
biopsi
taken
individu
increas
andor
acpa
posit
individu
arthralgia
without
evid
arthriti
patient
earli
ra
show
elev
level
cell
profil
compar
healthi
control
wherea
differ
found
cell
profil
establish
ra
howev
presenc
cell
seem
associ
diseas
protect
rather
exacerb
likewis
pgia
model
defici
mice
eventu
succumb
sever
arthriti
probabl
result
increas
level
pia
rat
develop
sever
chronic
arthriti
da
rat
consist
find
onset
diseas
mark
transit
depend
diseas
whether
cell
primari
sourc
establish
pia
remain
determin
unpublish
find
lab
show
cell
import
perpetu
chronic
pia
suggest
cell
may
play
specif
role
transit
chronic
diseas
jt
sh
rh
unpublish
result
would
consist
notion
synovi
infiltr
cell
may
play
specif
role
transit
acut
synov
chronic
inflamm
ra
shown
type
immun
respons
essenti
develop
pia
skew
sole
depend
mhcii
allel
rat
carri
mhcii
allel
skew
immun
respons
toward
cell
dln
develop
sever
arthriti
show
earlier
diseas
onset
rat
carri
mhcii
allel
skew
immun
respons
toward
immun
respons
essenti
onset
pia
mediat
immun
necessari
establish
chronic
arthriti
daolahsd
harlan
europ
netherland
maintain
barrier
facil
mate
specif
pathogen
free
spf
accord
current
felasa
guidelin
includ
pathogen
parvoviru
sendai
viru
hantaan
viru
coronaviru
reoviru
cytomegaloviru
pasteurellacea
mycoplasma
pulmoni
anim
kept
environ
h
light
h
dark
cycl
hous
individu
ventil
ivc
contain
wood
shave
fed
standard
rodent
chow
filter
water
ad
libitum
deriv
congen
strain
describ
previous
rat
strain
avail
open
resourc
rat
resourc
research
center
columbia
mo
induct
evalu
pia
da
rat
describ
recent
brief
pia
induc
singl
intraderm
inject
pristan
acro
organ
morri
plain
nj
usa
dorsal
side
tail
base
experi
perform
sex
day
rat
diseas
protect
strain
differ
treatment
group
hous
togeth
cage
wean
least
week
start
experi
arthriti
develop
monitor
daili
everi
second
day
use
macroscop
score
system
point
per
rat
describ
previous
brief
point
given
inflam
knuckl
toe
point
given
affect
ankl
total
point
per
paw
score
perform
blind
differ
investig
weight
loss
rat
includ
object
measur
diseas
sever
weight
chang
figur
indic
bodi
weight
diseas
onset
experi
approv
perform
accord
guidelin
swedish
nation
board
laboratori
anim
european
commun
council
direct
adopt
pia
transfer
describ
previous
modifi
follow
singl
cell
suspens
pair
inguin
ln
prepar
rt
ml
transfer
medium
contain
concanavalin
con
sigma
aldrich
fc
gibco
mgml
hepe
iuml
penicillin
mgml
streptomycin
invitrogen
life
technolog
dulbecco
mem
gibco
use
cell
strainer
bd
falcon
cell
strainer
rins
ml
transfer
medium
cell
ad
cultur
flask
transfer
medium
ad
final
volum
ml
cell
thereaft
incub
h
humidifi
atmospher
con
cell
transfer
centrifug
tube
bd
falcon
pellet
x
g
min
rt
wash
steril
pb
pellet
cell
gentli
resuspend
without
ad
new
pb
transfer
cell
strainer
place
clean
ml
centrifug
tube
wash
origin
tube
pb
tube
centrifug
cell
strainer
attach
x
g
collect
cell
cell
concentr
adjust
pb
cellsml
naiv
syngen
recipi
inject
intraven
iv
cell
cell
wash
cold
buffer
contain
bovin
serum
albumin
bsa
mm
merck
darmstadt
germani
resuspend
buffer
stain
mab
cellswel
ad
duplic
polypropylen
plate
bd
falcon
cytokin
stain
cell
resuspend
transfer
medium
see
without
con
seed
cellswel
duplic
treat
plate
cell
mix
equal
volum
medium
contain
ngml
phorbol
pma
ionomycin
brefeldin
incub
h
atmospher
cell
transfer
plate
wash
cold
buffer
stain
extracellularli
mab
fix
permeabil
bd
cytofixcytoperm
min
rt
follow
intracellular
stain
cell
cultur
absenc
pma
ionomycin
serv
neg
control
intracellular
detect
cell
incub
min
rt
fixationpermeabil
buffer
ebiosci
thereaft
wash
twice
buffer
bd
permwash
stain
fmo
control
use
experi
livedead
violet
invitrogen
carlsbad
ca
use
gate
live
cell
analys
duplic
sampl
pool
prior
acquisit
bd
flow
cytomet
data
analyz
flowjo
tree
star
inc
ashland
follow
fitc
alexa
fluor
pe
apc
alexa
fluor
biotin
conjug
antibodi
use
flow
cytometri
purchas
bd
pharmingen
san
diego
ca
tcr
purchas
biolegend
san
diego
ca
tcr
tcr
purchas
unlabel
lsbio
seattl
wa
usa
use
secondari
polyclon
goat
antibodi
biolegend
purchas
ebiosci
san
diego
ca
polyclon
mous
purchas
r
system
mous
produc
b
kindli
provid
dr
toma
olsson
describ
previous
antibodi
clone
mous
isotyp
control
antibodi
clone
obtain
bio
x
cell
west
lebanon
nh
usa
rat
evalu
elisa
use
supernat
con
cell
cultur
antibodi
administr
sc
ml
steril
pb
mgml
flank
tail
base
ml
mg
total
per
rat
time
point
describ
previous
target
pristan
dln
prime
phase
pia
day
pristan
inject
antibodi
treatment
diseas
day
pristan
inject
administr
iv
use
volum
concentr
use
sc
inject
stimul
coat
overnight
pb
iln
cell
collect
rat
day
post
seed
cellswel
cultur
h
solubl
ad
cultur
start
final
concentr
cultur
supernat
quantifi
elisa
use
biolegend
pn
r
system
captur
antibodi
togeth
biotinyl
biolegend
pn
r
system
detect
streptavidin
delfia
perkinelm
use
secondari
reagent
fluoresc
detect
synergi
micropl
reader
valu
repres
arbitrari
unit
au
singl
cell
suspens
prepar
iln
wash
resuspend
ml
cold
mac
buffer
bsa
mm
edta
cellsml
ten
million
cell
ml
incub
antibodi
tcr
min
antibodi
bd
cell
wash
mac
buffer
resuspend
ml
buffer
dynabead
pan
mous
igg
dynal
oslo
norway
ad
cell
incub
rotat
minut
wash
mac
buffer
nk
cell
nk
cell
b
cell
cell
cell
remov
magnet
deplet
cell
wash
resuspend
mac
buffer
incub
minut
microbead
miltenyi
biotec
gtf
goteborg
sweden
label
cell
posit
select
miltenyi
biotec
isol
cell
store
use
puriti
cell
assess
flow
cytometri
stain
typic
cell
pellet
allow
thaw
slightli
resuspend
rlt
buffer
qiagen
nordic
ballerup
denmark
contain
autom
rna
isol
perform
qiacub
robot
use
rneasi
extract
reagent
qiagen
dnase
digest
qiagen
rna
quantiti
puriti
assess
nanodrop
nanodrop
technolog
wilmington
de
rna
sampl
dilut
depc
treat
water
ambion
complementari
dna
cdna
synthes
use
high
capac
cdna
revers
transcript
kit
appli
biosystem
foster
citi
ca
usa
reaction
primer
design
http
obtain
rtprimerdb
medgenugentbertprimerdb
tabl
pcr
master
mix
appli
biosystem
foster
citi
ca
use
pcr
reaction
accord
manufactur
recommend
quantit
perform
abi
prism
ht
sequenc
detect
system
appli
biosystem
specif
effici
primer
valid
prior
use
absolut
quantif
express
target
gene
determin
rel
quantif
method
normal
geometr
mean
refer
gene
arbp
gusb
author
conflict
interest
declar
